CosmosID offers end-to-end microbiome science solutions from discovery through clinical validation: short- and long-read DNA sequencing, metabolomics, RNA sequencing, multi-omics analysis and systems biology expertise. Pipelines are supported by CLIA-certified & ICH-GCP compliant NGS, metabolomic, and advanced bioinformatics solutions. CosmosID also offers a user-friendly cloud software for microbiome comparative analysis and statistics.
Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has 62 NGS-related patents, as well as nearly 20,000 SCI articles with a total impact factor of nearly 120,000, including publications in first tiers journals such as Cell, Nature and Science. As the largest NGS service provider headquartered in Beijing with branches in Hong Kong China, US, UK, Singapore, Netherlands, and Japan, Novogene was founded in 2011 and has been growing rapidly over the past few years.
